Travere Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Travere Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q3 2014 to Q3 2024.
  • Travere Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $17.1M, a 32.6% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $17.1M +$4.2M +32.6% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $16.9M +$5.13M +43.5% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $19.3M +$8.27M +75% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $10.7M -$23K -0.22% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $12.9M +$1.82M +16.4% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $11.8M +$982K +9.09% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $11M +$196K +1.81% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $10.7M -$385K -3.48% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $11.1M -$23.8M -68.2% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $10.8M -$23.6M -68.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $10.8M -$24.2M -69.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $11.1M +$3.26M +41.7% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $34.9M +$1.18M +3.51% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $34.4M +$20.5M +147% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $35M +$28.2M +415% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $7.81M -$6.9M -46.9% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $33.7M +$21.2M +171% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $13.9M +$1.19M +9.39% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $6.8M -$6.67M -49.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $14.7M +$7M +90.8% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $12.5M +$5.06M +68.4% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $12.7M +$7.35M +137% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $13.5M +$7.01M +109% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $7.71M +$2.15M +38.8% Dec 31, 2018 10-K 2020-02-24
Q3 2018 $7.39M +$292K +4.11% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $5.35M +$1.72M +47.5% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $6.46M +$2.8M +76.4% Mar 31, 2018 10-Q/A 2018-07-06
Q4 2017 $5.56M -$1.81M -24.6% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $7.1M +$5.13M +260% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $3.63M +$1.77M +95.2% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $3.66M +$1.8M +96.9% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $7.36M +$5.51M +296% Dec 31, 2016 10-K/A 2018-07-06
Q3 2016 $1.97M -$32K -1.6% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $1.86M -$157K -7.79% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $1.86M -$128K -6.46% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $1.86M -$406K -17.9% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $2.01M +$84.7K +4.41% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $2.02M Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $1.99M Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $2.27M Dec 31, 2014 10-K 2016-02-26
Q3 2014 $1.92M Sep 30, 2014 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.